|Articles|October 1, 2011
Pharmaceutical Technology Europe
- Pharmaceutical Technology Europe-10-01-2011
- Volume 23
- Issue 10
Time Is Of The Essence
Author(s)Control, a senior compliance officer
Giving contamination time to build up can cause headaches for more than just your company.
Advertisement
Giving contamination time to build up can cause headaches for more than just your company.
This article was also published in our US sister publication Pharmaceutical Technology and can be read
Articles in this issue
almost 15 years ago
Overcoming The Distancealmost 15 years ago
Novel Excipients: A Rare Speciesalmost 15 years ago
Standing Out In The Outsourcing Crowdalmost 15 years ago
Why Good Records Management Is Keyalmost 15 years ago
Europe Edging Towards Electronic Prescribingalmost 15 years ago
EU Market Challengesalmost 15 years ago
Challenges In The Changing Outsourcing Landscapealmost 15 years ago
Taking It For Grantedalmost 15 years ago
Newsalmost 15 years ago
Trends and Challenges in Biologics OutsourcingAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The Implications of Isatuximab-irfc’s FDA Approval for Multiple Myeloma
2
The FDA Moves to Modernize Drug Manufacturing Registration
3
PharmTech Weekly Roundup–July 10, 2026
4
What the Ocrelizumab Deal Does for the Multiple Sclerosis Biosimilar Pipeline
5
